Please login to the form below

Not currently logged in


This page shows the latest peptide news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics to tackle AMR with government funding

Bicycle Therapeutics to tackle AMR with government funding

Bicycle's expertise is in developing a unique class of chemically synthesized medicines based on its proprietary bicyclic peptide (Bicycle) platform, which aims to address therapeutic needs unreachable with existing treatment

Latest news

More from news
Approximately 0 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • Regeneron and Bluebird sign $100m cell therapies deal Regeneron and Bluebird sign $100m cell therapies deal

    peptides, while Bluebird will contribute its own cutting-edge expertise in gene transfer and cell therapy.

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... licence agreement in January with respect to calcitonin gene-related peptide

  • Gene therapy Gene therapy

    Finally, looking beyond liposome versus viral delivery, alternative technologies such as new polymers, conjugates, vesicles, dendrimers and peptide nanoparticles, such as LipTide (an ‘artificial virus’), urgently need investment and further

  • Deal Watch - May 2017 Deal Watch - May 2017

    peptide discovery platform.  The published maximum deal value is $1.15bn if everything goes according to plan with every development.  Needless to say the upfront payment has not been published.  However ... most advanced is an immuno-oncology

  • Deal Watch February 2017 Deal Watch February 2017

    Acquisition - company. 705. Advaxis/ SELLAS Life Sciences Group. Advaxis' Lm-based antigen delivery technology with SELLAS’ WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S) (pre-clinical).

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • JPT Peptide Technologies

    JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products &kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics ... JPT Peptide Technologies.

  • Creative Peptides

    Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. ... We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company Conferences, Events and Exhibition Stands is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....